Abstract
From the first quarter of 2014, a new generation of transcatheter valves (Fig. 8.1) has CE mark approval for clinical use in Europe and under scrutiny for FDA approval in the United States. These new valves aim to overcome or to reduce the major limitations of first-generation valves (Edwards XT and CoreValve) as paravalvular leak, vascular complications, cardiac rhythm disturbances, and stroke. We describe below the technical features and the first clinical results of the new transfemoral devices.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Meredith IT, et al. Early results from the CoreValve Evolut R CE Study (2101–295). Presented at the annual meeting of the American College of Cardiology. March 14, 2015.
Binder RK, Rodés-Cabau J, Wood DA, Mok M, Leipsic J, De Larochellière R, Toggweiler S, Dumont E, Freeman M, Willson AB, Webb JG. A new balloon-expandable transcatheter heart valve. J Am Coll Cardiol Intv. 2013;6(3):293–300.
Kodali S on behalf of PARTNER investigators. American College of Cardiology (ACC) 2015 March 15, 2015; San Diego.
Meredith AM, et al. Reprise I. Euro Interv. 2014;9(11):1264–70.
Meredith et al. REPRISE II Trial JACC 2014.
Van Mieghem NM, on behalf of the RESPOND Investigators. First report from the RESPOND study: post-market evaluation of a fully repositionable and retrievable aortic valve in 250 patients treated in routine clinical practice. EuroPCR 2015.
Ganesh Manoharan On behalf of the Portico™ Valve CE Mark Investigators. Multicentre clinical study evaluating a novel resheathable self-expanding transcatheter aortic valve system preliminary results: acute and 1-year outcomes EuroPCR 2014 oral presentation.
Schofer J, Colombo A, Klugmann S, et al. Prospective multicenter evaluation of the direct flow medical transcatheter aortic valve. J Am Coll Cardiol. 2014;63(8):763–8.
Kempfert J, Holzhey D, Hofmann S, Girdauskas E, Treede H, Schröfel H, Thielmann M, Walther T. First registry results from the newly approved ACURATE TA™ TAVI system. Eur J Cardiothorac Surg. 2015;48(1):137–41.
Möllmann H, Diemert P, Grube E, Baldus S, Kempfert J, Abizaid A. Symetis ACURATE TF™ aortic bioprosthesis. Euro Interv. 2013;9:S107–10.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Bedogni, F., Agnifili, M., Testa, L. (2017). Current and Next Generation of Transcatheter Valves. In: Reimers, B., Moussa, I., Pacchioni, A. (eds) Percutaneous Interventions for Structural Heart Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-43757-6_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-43757-6_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-43755-2
Online ISBN: 978-3-319-43757-6
eBook Packages: MedicineMedicine (R0)